Literature DB >> 30281988

A Candida auris Outbreak and Its Control in an Intensive Care Setting.

David W Eyre1, Anna E Sheppard1, Hilary Madder1, Ian Moir1, Ruth Moroney1, T Phuong Quan1, David Griffiths1, Sophie George1, Lisa Butcher1, Marcus Morgan1, Robert Newnham1, Mary Sunderland1, Tiphanie Clarke1, Dona Foster1, Peter Hoffman1, Andrew M Borman1, Elizabeth M Johnson1, Ginny Moore1, Colin S Brown1, A Sarah Walker1, Tim E A Peto1, Derrick W Crook1, Katie J M Jeffery1.   

Abstract

BACKGROUND: Candida auris is an emerging and multidrug-resistant pathogen. Here we report the epidemiology of a hospital outbreak of C. auris colonization and infection.
METHODS: After identification of a cluster of C. auris infections in the neurosciences intensive care unit (ICU) of the Oxford University Hospitals, United Kingdom, we instituted an intensive patient and environmental screening program and package of interventions. Multivariable logistic regression was used to identify predictors of C. auris colonization and infection. Isolates from patients and from the environment were analyzed by whole-genome sequencing.
RESULTS: A total of 70 patients were identified as being colonized or infected with C. auris between February 2, 2015, and August 31, 2017; of these patients, 66 (94%) had been admitted to the neurosciences ICU before diagnosis. Invasive C. auris infections developed in 7 patients. When length of stay in the neurosciences ICU and patient vital signs and laboratory results were controlled for, the predictors of C. auris colonization or infection included the use of reusable skin-surface axillary temperature probes (multivariable odds ratio, 6.80; 95% confidence interval [CI], 2.96 to 15.63; P<0.001) and systemic fluconazole exposure (multivariable odds ratio, 10.34; 95% CI, 1.64 to 65.18; P=0.01). C. auris was rarely detected in the general environment. However, it was detected in isolates from reusable equipment, including multiple axillary skin-surface temperature probes. Despite a bundle of infection-control interventions, the incidence of new cases was reduced only after removal of the temperature probes. All outbreak sequences formed a single genetic cluster within the C. auris South African clade. The sequenced isolates from reusable equipment were genetically related to isolates from the patients.
CONCLUSIONS: The transmission of C. auris in this hospital outbreak was found to be linked to reusable axillary temperature probes, indicating that this emerging pathogen can persist in the environment and be transmitted in health care settings. (Funded by the National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University and others.).

Entities:  

Mesh:

Year:  2018        PMID: 30281988     DOI: 10.1056/NEJMoa1714373

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  111 in total

1.  Preparing your healthcare facility for the new fungus among us: An infection preventionist's guide to Candida auris.

Authors:  Tina Z Wang; Kindra N White; Jillian Villani Scarr; Matthew S Simon; David P Calfee
Journal:  Am J Infect Control       Date:  2020-07       Impact factor: 2.918

2.  Focus on infection.

Authors:  Ignacio Martin-Loeches; Garyphallia Poulakou; Saad Nseir
Journal:  Intensive Care Med       Date:  2019-06-18       Impact factor: 17.440

3.  MycopathologiaGENOMES: The New 'Home' for the Publication of Fungal Genomes.

Authors:  Micheál Mac Aogáin; Vishnu Chaturvedi; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2019-08-10       Impact factor: 2.574

4.  Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris.

Authors:  Jeffrey M Rybak; Laura A Doorley; Andrew T Nishimoto; Katherine S Barker; Glen E Palmer; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

5.  Fungal immunology in clinical practice: Magical realism or practical reality?

Authors:  Christina C Chang; Stuart M Levitz
Journal:  Med Mycol       Date:  2019-06-01       Impact factor: 4.076

Review 6.  Candida auris: a fungus with identity crisis.

Authors:  Taissa Vila; Ahmed S Sultan; Daniel Montelongo-Jauregui; Mary Ann Jabra-Rizk
Journal:  Pathog Dis       Date:  2020-06-01       Impact factor: 3.166

7.  Identification of Candida auris by Use of the Updated Vitek 2 Yeast Identification System, Version 8.01: a Multilaboratory Evaluation Study.

Authors:  Georges Ambaraghassi; Philippe J Dufresne; Simon F Dufresne; Émilie Vallières; José F Muñoz; Christina A Cuomo; Elizabeth L Berkow; Shawn R Lockhart; Me-Linh Luong
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

8.  General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation.

Authors:  Dora E Corzo-Leon; Mark Peacock; Patricia Rodriguez-Zulueta; Grace J Salazar-Tamayo; Donna M MacCallum
Journal:  Med Mycol       Date:  2021-07-06       Impact factor: 4.076

Review 9.  A framework for microbiome science in public health.

Authors:  Jeremy E Wilkinson; Eric A Franzosa; Christine Everett; Chengchen Li; Frank B Hu; Dyann F Wirth; Mingyang Song; Andrew T Chan; Eric Rimm; Wendy S Garrett; Curtis Huttenhower
Journal:  Nat Med       Date:  2021-04-05       Impact factor: 53.440

10.  Human Infections Caused by Clonally Related African Clade (Clade III) Strains of Candida auris in the Greater Houston Region.

Authors:  S Wesley Long; Matthew Ojeda Saavedra; Paul A Christensen; James M Musser; Randall J Olsen
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.